The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Open accessAbstract
AIMS: To develop a novel nanomedicine approach for the treatment of multidrug-resistant (MDR) cancer by combining an anticancer drug and suppressors of cellular resistance within one multifunctional nanocarrier-based delivery system (NDS). MATERIALS & METHODS: The NDS consisted of cationic liposomes (carrier, 100-140 nm), doxorubicin (DOX, anticancer drug), siRNA targeted to MRP1 and BCL2 mRNA (suppressors of pump and nonpump cellular-resistance, respectively). The resulting approximately 500 nm complex has a zeta potential of +4 mV. RESULTS & DISCUSSION: The NDS provides an effective co-delivery of DOX and siRNA as well as cell-death induction and suppression of cellular resistance in MDR lung cancer cells. CONCLUSION: We demonstrate NDS-enhanced efficiency of chemotherapy to a level that cannot be achieved by applying its components separately.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
BCL-2 family members and the mitochondria in apoptosis
Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,641
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
Dysregulation of Apoptosis in Cancer
Reed, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2941 · Cited by 987
Polymer–drug conjugates: Progress in polymeric prodrugs
Khandare, J., & Minko, T. (2006) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.09.004 · Cited by 639
Self-citationPolymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide
Dharap, S. S., Wang, Y., Chandna, P., Khandare, J. J., Qiu, B., Gunaseelan, S., Sinko, P. J., Stein, S., Farmanfarmaian, A., & Minko, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504274102 · Cited by 340
Self-citationWu, H., Hait, W. N., & Yang, J. (2003) · PubMed · Cited by 289
Holinger, E. P., Chittenden, T., & Lutz, R. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13298 · Cited by 254
Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.
Schroeder, A., Avnir, Y., Weisman, S., Najajreh, Y., Gabizon, A., Talmon, Y., Kost, J., & Barenholz, Y. (2007) · Langmuir · doi:10.1021/la0631668 · Cited by 239
Saad, M., Garbuzenko, O. B., Ber, E., Chandna, P., Khandare, J. J., Pozharov, V. P., & Minko, T. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.024 · Cited by 238
Self-citationAn Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy
Takara, K., Sakaeda, T., & Okumura, K. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775201965 · Cited by 236
Cationic lipids enhance siRNA-mediated interferon response in mice
Ma, Z., Li, J., He, F., Wilson, A., Pitt, B., & Li, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.041 · Cited by 225
Surface-Modified and Internally Cationic Polyamidoamine Dendrimers for Efficient siRNA Delivery
Patil, M. L., Zhang, M., Betigeri, S., Taratula, O., He, H., & Minko, T. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8000722 · Cited by 213
Self-citationHomolya, L., Váradi, A., & Sarkadi, B. (2003) · BioFactors · doi:10.1002/biof.5520170111 · Cited by 208
Molecular Targeting of Drug Delivery Systems to Cancer
Minko, T., Dharap, S., Pakunlu, R., & Wang, Y. (2004) · Current Drug Targets · doi:10.2174/1389450043345443 · Cited by 175
Self-citationMolecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides
Dharap, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00209-8 · Cited by 172
Regulation of apoptosis by BH3 domains in a cell-free system
Cosulich, S. C., Worrall, V., Hedge, P. J., Green, S., & Clarke, P. R. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00410-6 · Cited by 166
Pakunlu, R. I., Wang, Y., Tsao, W., Pozharov, V. P., Cook, T. J., & Minko, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0001 · Cited by 148
Self-citationBiomaterials for Delivery and Targeting of Proteins and Nucleic Acids
Mahato, R. I. (2004) · CRC Press eBooks · doi:10.1201/9780203492321 · Cited by 145
Pakunlu, R. I., Wang, Y., Saad, M., Khandare, J. J., Starovoytov, V., & Minko, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.010 · Cited by 134
Self-citationBuyens, K., Lucas, B., Raemdonck, K., Braeckmans, K., Vercammen, J., Hendrix, J., Engelborghs, Y., Smedt, S. C. D., & Sanders, N. N. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.024 · Cited by 133
Minko, T., Kopečková, P., & Kopeček, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018959029186 · Cited by 131
Self-citationWatts, R., Hawkins, C. L., Ponka, P., & Richardson, D. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602515103 · Cited by 128
Targeted Delivery of Small Interfering RNA: Approaching Effective Cancer Therapies
Pirollo, K. F., & Chang, E. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5810 · Cited by 121
Flescher, E. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.03.001 · Cited by 115
Zhou, J., Liu, M., Aneja, R., Chandra, R., Lage, H., & Joshi, H. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1779 · Cited by 112
Pakunlu, R. I., Cook, T. J., & Minko, T. (2003) · Pharmaceutical Research · doi:10.1023/a:1022687617318 · Cited by 109
Self-citationRole of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins
Lutz, R. J. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280051 · Cited by 108
Glutathione Export during Apoptosis Requires Functional Multidrug Resistance-associated Proteins
Hammond, C. L., Marchan, R., Krance, S. M., & Ballatori, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611019200 · Cited by 103
New Generation of Liposomal Drugs for Cancer
Minko, T., Pakunlu, R. I., Wang, Y., Khandare, J. J., & Saad, M. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778699095 · Cited by 99
Self-citationMinko, T., Kopečková, P., & Kopec̆ek, J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00186-2 · Cited by 97
Self-citationde Menezes, D. E. L., Hudon, N. J., McIntosh, N. L., & Mayer, L. D. (2000) · PubMed · Cited by 93
Novel Polymeric Prodrug with Multivalent Components for Cancer Therapy
Khandare, J. J., Chandna, P., Wang, Y., Pozharov, V. P., & Minko, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098855 · Cited by 83
Self-citationMultidrug resistance in non-small-cell lung cancer
Scagliotti, G. V., Novello, S., & Selvaggi, G. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_5.s83 · Cited by 82
Hsia, T.-C., Lin, C., Wang, J. J., Ho, S., & Kao, A. (2002) · Lung · doi:10.1007/s004080000091 · Cited by 74
Targeted Proapoptotic Anticancer Drug Delivery System
Chandna, P., Saad, M., Wang, Y., Ber, E., Khandare, J. J., Vetcher, A. A., Soldatenkov, V. A., & Minko, T. (2007) · Molecular Pharmaceutics · doi:10.1021/mp070053o · Cited by 69
Self-citationWang, Y., Saad, M., Pakunlu, R. I., Khandare, J. J., Garbuzenko, O. B., Vetcher, A. A., Soldatenkov, V. A., Pozharov, V. P., & Minko, T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2020 · Cited by 57
Self-citationBiochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs.
Aszalós, A., & Ross, D. D. (1998) · PubMed · Cited by 53
Kigawa, J., Minagawa, Y., Cheng, X., et al. (1998) · PubMed · Cited by 50
Kassim, S. K., Ali, H. S., Sallam, M. M., Fayed, S. T., Seada, L., abd-Elkawy, E., Seada, M. A., & Khalifa, A. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00026-0 · Cited by 44
Lutz, M., Baniahmad, A., & Renkawitz, R. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280386 · Cited by 35
de Menezes, D. E. L., Hu, Y., & Mayer, L. D. (2003) · Journal of Experimental Therapeutics and Oncology · doi:10.1046/j.1359-4117.2003.01075.x · Cited by 22
DOTAP/UDCA vesicles: novel approach in oligonucleotide delivery
Ruozi, B., Battini, R., Montanari, M., Mucci, A., Tosi, G., Forni, F., & Vandelli, M. A. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2007.01.002 · Cited by 20
Role of Cholesterol, DOTAP, and DPPC in Prostasome/Spermatozoa Interaction and Fusion
Palmerini, C. A., Cametti, C., Sennato, S., Gaudino, D., Carlini, E., Bordi, F., & Arienti, G. (2006) · The Journal of Membrane Biology · doi:10.1007/s00232-006-0009-2 · Cited by 18
Multifunctional Nanotherapeutics for Cancer
Minko, T., Khandare, J. J., Vetcher, A. A., Солдатенков, В. А., Garbuzenko, O. B., Saad, M., & Pozharov, V. P. (2008) · Fundamental biomedical technologies · doi:10.1007/978-0-387-76554-9_10 · Cited by 13
Self-citationAkita, H., & Harashima, H. (2008) · KARGER eBooks · doi:10.1159/000125560 · Cited by 9
Cited by
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00193 · Cited by 1,451
Meng, H., Liong, M., Xia, T., Li, Z., Ji, Z., Zink, J. I., & Nel, A. E. (2010) · ACS Nano · doi:10.1021/nn100690m · Cited by 902
Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide
Zhang, W., Guo, Z., Huang, D., Liu, Z., Guo, X., & Zhong, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.071 · Cited by 891
Metadata
- Authors
- Saad, M., Garbuzenko, O. B., & Minko, T.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2008-11-24
- Volume
- 3
- Issue
- 6
- Pages
- 761-776
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2150702593
- Cited by
- 367
- References
- 48
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.